@Sector . The current clinical grading systems have been shown to have imperfectionsparticularly in Grade 3 patients . The most accurate classifications have come form ST2 bio marker scores incorporated into the MAGIC algorithms.
As to your hysterical claim that I am talking “tripe” , it is obvious you do not understand the Glucksberg or IMBTR grading systems. Grade 2/B is mild &Grade 4/D is severe. In our trial GVHD001 we had 49% of patients with overall Grade 4/D classification and 89% with either Grade C/D . In Cynatas trial , none of your patients had overall Grade D although (from memory ) I think you had 2 out of 16 patients with one organ grade at severe.
https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2141.1997.1112925.x
It really will not do…lecturing people on this thread when you have no appreciation of the subject. If I were you I would feel totally embarrassed…calling people out when you are totally wrong….shameful.
For your homework you can read the peer reviewed papers shown in the abstract below.
Have a nice weekend !
Ann: MSB Presents at Edison Group Global Healthcare Conference, page-222
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.080(5.50%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $5.321M | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12214 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 37660 | 5 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |